United Therapeutics (UTHR) Total Debt Growth (3y) (2013 - 2025)
United Therapeutics (UTHR) Total Debt Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 92.83% |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 72.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -37.00% |
| Dec 31, 2024 | -27.89% |
| Sep 30, 2024 | -20.63% |
| Jun 30, 2024 | -14.50% |
| Mar 31, 2024 | -9.14% |
| Dec 31, 2023 | -4.35% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -2.00% |
| Sep 30, 2022 | -7.17% |
| Jun 30, 2022 | -8.67% |
| Mar 31, 2022 | -8.67% |
| Dec 31, 2021 | 16.96% |
| Sep 30, 2021 | 47.36% |
| Jun 30, 2021 | 47.36% |
| Mar 31, 2021 | 47.36% |
| Dec 31, 2020 | 16.96% |
| Sep 30, 2020 | 47.36% |
| Jun 30, 2020 | 47.36% |